Economies of scale: Genetically-targeted therapies

What does ‘good governance’ look like for genome editing?

Expanding the public and patient role in medical regulation

Making the UK a science superpower – will policy moves pay off for health?

Calls to review regulation of direct-to-consumer genetic testing

Putting Genome UK into practice: genomic healthcare strategy implementation

Bringing order to polygenic score reporting

Genomic surveillance in the roll out of vaccines

A vision for the future of clinical research

International lessons for personalised medicine